The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 342:15-20 January 6, 2000 Number 1
NextNext

Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Stephanie J. Schrag, D.Phil., Sara Zywicki, M.P.H., Monica M. Farley, M.D., Arthur L. Reingold, M.D., Lee H. Harrison, M.D., Lewis B. Lefkowitz, M.D., James L. Hadler, M.D., Richard Danila, M.D., Paul R. Cieslak, M.D., and Anne Schuchat, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Group B streptococcal infections are a leading cause of neonatal mortality, and they also affect pregnant women and the elderly. Many cases of the disease in newborns can be prevented by the administration of prophylactic intrapartum antibiotics. In the 1990s, prevention efforts increased. In 1996, consensus guidelines recommended use of either a risk-based or a screening-based approach to identify candidates for intrapartum antibiotics. To assess the effects of the preventive efforts, we analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998.

Methods Active, population-based surveillance was conducted in selected counties of eight states. A case was defined by the isolation of group B streptococci from a normally sterile site. Census and live-birth data were used to calculate the race-specific incidence of disease; national projections were adjusted for race.

Results Disease in infants less than seven days old accounted for 20 percent of all 7867 group B streptococcal infections. The incidence of early-onset neonatal infections decreased by 65 percent, from 1.7 per 1000 live births in 1993 to 0.6 per 1000 in 1998. The excess incidence of early-onset disease in black infants, as compared with white infants, decreased by 75 percent. Projecting our findings to the entire United States, we estimate that 3900 early-onset infections and 200 neonatal deaths were prevented in 1998 by the use of intrapartum antibiotics. Among pregnant girls and women, the incidence of invasive group B streptococcal disease declined by 21 percent. The incidence among nonpregnant adults did not decline.

Conclusions Over a six-year period, there has been a substantial decline in the incidence of group B streptococcal disease in newborns, including a major reduction in the excess incidence of these infections in black infants. These improvements coincide with the efforts to prevent perinatal disease by the wider use of prophylactic intrapartum antibiotics.


Source Information

From the Centers for Disease Control and Prevention, Atlanta (S.J.S., S.Z., A.S.); the Emory University School of Medicine and Veterans Affairs Medical Services, Atlanta (M.M.F.); the School of Public Health, University of California, Berkeley (A.L.R.); the Johns Hopkins School of Hygiene and Public Health, Baltimore (L.H.H.); Vanderbilt Medical Center, Nashville (L.B.L.); the Connecticut Department of Public Health, Hartford (J.L.H.); the Minnesota Department of Health, Minneapolis (R.D.); and the Department of Human Resources, Portland, Oreg. (P.R.C.). The members of the surveillance team are listed in the Appendix.

Address reprint requests to Dr. Schrag at the Respiratory Diseases Branch, MS-C23, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, or at zha6{at}cdc.gov.

Full Text of this Article


Related Letters:

Reducing Neonatal Group B Streptococcal Disease
Wendel G. D., McIntire D. J., Leveno K. J.
Extract | Full Text  
N Engl J Med 2000; 342:1367-1368, May 4, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.